Innovating Works

HCDCP/MOH

A stranger
E-RARE-2: ERA Net on Rare Diseases Rare diseases represent an important public-health issue, affecting 26-30 million persons across Europe, and a major challenge for research....
financed
TRANSCAN: ERA NET on Translational Cancer Research KENTROU ELEGHOU & PROLIPSIS NOSIMATON participó en un FP7: Cancer is a worldwide health burden and a major public health challenge in Europe, responsible for 25% of all deaths; a situation expected t...
financed
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.